0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Parkinson's Disease (PD) Drugs - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-22E2836
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Parkinson s Disease PD Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Parkinson's Disease (PD) Drugs - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-22E2836
Report
December 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Parkinson's Disease (PD) Drugs - Market Size

The global Parkinson's Disease (PD) Drugs market size is expected to reach US$ 7419.9 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029.

Parkinson's Disease (PD) Drugs -  Market

Parkinson's Disease (PD) Drugs - Market

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The market is mainly driven by the significant applications of Parkinson's Disease (PD) Drugs in various end use industries. The expanding demands from the Hospital and Family, are propelling Parkinson's Disease (PD) Drugs market. Dopamine Agonist, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoamine Oxidase Inhibitors segment is estimated at % CAGR for the next seven-year period.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parkinson's Disease (PD) Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Parkinson's Disease (PD) Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parkinson's Disease (PD) Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parkinson's Disease (PD) Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parkinson's Disease (PD) Drugs covered in this report include Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, AbbVie, Abital Pharma, Addex Therapeutics, Biogen and Eisai, etc.
The global Parkinson's Disease (PD) Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer

Scope of Parkinson's Disease (PD) Drugs - Market Report

Report Metric Details
Report Name Parkinson's Disease (PD) Drugs - Market
Forecasted market size in 2029 US$ 7419.9 million
CAGR 4.3%
Forecasted years 2023 - 2029
Global Parkinson's Disease (PD) Drugs market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parkinson's Disease (PD) Drugs market, Segment by Type:
  • Dopamine Agonist
  • Monoamine Oxidase Inhibitors
  • Acetylcholinesterase Inhibitors
  • Glutamate Inhibitors
Global Parkinson's Disease (PD) Drugs market, by Application
  • Hospital
  • Family
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Parkinson's Disease (PD) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Parkinson's Disease (PD) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Parkinson's Disease (PD) Drugs - Market size in 2029?

Ans: The Parkinson's Disease (PD) Drugs - Market size in 2029 will be US$ 7419.9 million.

What are the Application segmentation covered in the Parkinson's Disease (PD) Drugs - Market report?

Ans: The Applications covered in the Parkinson's Disease (PD) Drugs - Market report are Hospital, Family

What are the Type segmentation covered in the Parkinson's Disease (PD) Drugs - Market report?

Ans: The Types covered in the Parkinson's Disease (PD) Drugs - Market report are Dopamine Agonist, Monoamine Oxidase Inhibitors, Acetylcholinesterase Inhibitors, Glutamate Inhibitors

1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Parkinson's Disease (PD) Drugs Product Overview
1.2 Parkinson's Disease (PD) Drugs Market Segment by Type
1.2.1 Dopamine Agonist
1.2.2 Monoamine Oxidase Inhibitors
1.2.3 Acetylcholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Global Parkinson's Disease (PD) Drugs Market Size by Type
1.3.1 Global Parkinson's Disease (PD) Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Parkinson's Disease (PD) Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Parkinson's Disease (PD) Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Parkinson's Disease (PD) Drugs Sales Breakdown by Type (2018-2023)
2 Global Parkinson's Disease (PD) Drugs Market Competition by Company
2.1 Global Top Players by Parkinson's Disease (PD) Drugs Sales (2018-2023)
2.2 Global Top Players by Parkinson's Disease (PD) Drugs Revenue (2018-2023)
2.3 Global Top Players by Parkinson's Disease (PD) Drugs Price (2018-2023)
2.4 Global Top Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Parkinson's Disease (PD) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
2.8 Key Manufacturers Parkinson's Disease (PD) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parkinson's Disease (PD) Drugs Status and Outlook by Region
3.1 Global Parkinson's Disease (PD) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Parkinson's Disease (PD) Drugs Historic Market Size by Region
3.2.1 Global Parkinson's Disease (PD) Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Parkinson's Disease (PD) Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Parkinson's Disease (PD) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Parkinson's Disease (PD) Drugs Forecasted Market Size by Region
3.3.1 Global Parkinson's Disease (PD) Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Parkinson's Disease (PD) Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Parkinson's Disease (PD) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Parkinson's Disease (PD) Drugs by Application
4.1 Parkinson's Disease (PD) Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Family
4.2 Global Parkinson's Disease (PD) Drugs Market Size by Application
4.2.1 Global Parkinson's Disease (PD) Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Parkinson's Disease (PD) Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Parkinson's Disease (PD) Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Parkinson's Disease (PD) Drugs Sales Breakdown by Application (2018-2023)
5 North America Parkinson's Disease (PD) Drugs by Country
5.1 North America Parkinson's Disease (PD) Drugs Historic Market Size by Country
5.1.1 North America Parkinson's Disease (PD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Parkinson's Disease (PD) Drugs Sales in Value by Country (2018-2023)
5.2 North America Parkinson's Disease (PD) Drugs Forecasted Market Size by Country
5.2.1 North America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Parkinson's Disease (PD) Drugs Sales in Value by Country (2024-2029)
6 Europe Parkinson's Disease (PD) Drugs by Country
6.1 Europe Parkinson's Disease (PD) Drugs Historic Market Size by Country
6.1.1 Europe Parkinson's Disease (PD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Parkinson's Disease (PD) Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Parkinson's Disease (PD) Drugs Sales in Value by Country (2018-2023)
6.2 Europe Parkinson's Disease (PD) Drugs Forecasted Market Size by Country
6.2.1 Europe Parkinson's Disease (PD) Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Parkinson's Disease (PD) Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Parkinson's Disease (PD) Drugs by Region
7.1 Asia-Pacific Parkinson's Disease (PD) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Parkinson's Disease (PD) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Value by Region (2024-2029)
8 Latin America Parkinson's Disease (PD) Drugs by Country
8.1 Latin America Parkinson's Disease (PD) Drugs Historic Market Size by Country
8.1.1 Latin America Parkinson's Disease (PD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Parkinson's Disease (PD) Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Parkinson's Disease (PD) Drugs Forecasted Market Size by Country
8.2.1 Latin America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Parkinson's Disease (PD) Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Parkinson's Disease (PD) Drugs by Country
9.1 Middle East and Africa Parkinson's Disease (PD) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Parkinson's Disease (PD) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
10.3.5 Novartis Recent Development
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Company Information
10.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
10.4.5 Teva Pharmaceutical Industries Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
10.5.5 AbbVie Recent Development
10.6 Abital Pharma
10.6.1 Abital Pharma Company Information
10.6.2 Abital Pharma Introduction and Business Overview
10.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
10.6.5 Abital Pharma Recent Development
10.7 Addex Therapeutics
10.7.1 Addex Therapeutics Company Information
10.7.2 Addex Therapeutics Introduction and Business Overview
10.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
10.7.5 Addex Therapeutics Recent Development
10.8 Biogen
10.8.1 Biogen Company Information
10.8.2 Biogen Introduction and Business Overview
10.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
10.8.5 Biogen Recent Development
10.9 Eisai
10.9.1 Eisai Company Information
10.9.2 Eisai Introduction and Business Overview
10.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
10.9.5 Eisai Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
10.10.5 Eli Lilly Recent Development
10.11 F. Hoffmann-La Roche
10.11.1 F. Hoffmann-La Roche Company Information
10.11.2 F. Hoffmann-La Roche Introduction and Business Overview
10.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered
10.11.5 F. Hoffmann-La Roche Recent Development
10.12 H. Lundbeck
10.12.1 H. Lundbeck Company Information
10.12.2 H. Lundbeck Introduction and Business Overview
10.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Products Offered
10.12.5 H. Lundbeck Recent Development
10.13 Impax Laboratories
10.13.1 Impax Laboratories Company Information
10.13.2 Impax Laboratories Introduction and Business Overview
10.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Products Offered
10.13.5 Impax Laboratories Recent Development
10.14 Kyowa Hakko Kirin
10.14.1 Kyowa Hakko Kirin Company Information
10.14.2 Kyowa Hakko Kirin Introduction and Business Overview
10.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Products Offered
10.14.5 Kyowa Hakko Kirin Recent Development
10.15 Otsuka Pharmaceutical
10.15.1 Otsuka Pharmaceutical Company Information
10.15.2 Otsuka Pharmaceutical Introduction and Business Overview
10.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Products Offered
10.15.5 Otsuka Pharmaceutical Recent Development
10.16 Pfizer
10.16.1 Pfizer Company Information
10.16.2 Pfizer Introduction and Business Overview
10.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Pfizer Parkinson's Disease (PD) Drugs Products Offered
10.16.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parkinson's Disease (PD) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
11.4 Parkinson's Disease (PD) Drugs Market Dynamics
11.4.1 Parkinson's Disease (PD) Drugs Industry Trends
11.4.2 Parkinson's Disease (PD) Drugs Market Drivers
11.4.3 Parkinson's Disease (PD) Drugs Market Challenges
11.4.4 Parkinson's Disease (PD) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parkinson's Disease (PD) Drugs Distributors
12.3 Parkinson's Disease (PD) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Dopamine Agonist
    Table 2. Major Company of Monoamine Oxidase Inhibitors
    Table 3. Major Company of Acetylcholinesterase Inhibitors
    Table 4. Major Company of Glutamate Inhibitors
    Table 5. Global Parkinson's Disease (PD) Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (K Pcs)
    Table 7. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Parkinson's Disease (PD) Drugs Market Share in Value by Type (2018-2023)
    Table 10. Global Parkinson's Disease (PD) Drugs Price by Type (2018-2023) & (USD/Pcs)
    Table 11. Global Parkinson's Disease (PD) Drugs Sales by Type (2024-2029) & (K Pcs)
    Table 12. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Parkinson's Disease (PD) Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Parkinson's Disease (PD) Drugs Price by Type (2024-2029) & (USD/Pcs)
    Table 16. North America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (K Pcs)
    Table 17. North America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
    Table 19. Europe Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
    Table 21. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
    Table 23. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
    Table 25. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Parkinson's Disease (PD) Drugs Sales by Company (2018-2023) & (K Pcs)
    Table 27. Global Parkinson's Disease (PD) Drugs Sales Share by Company (2018-2023)
    Table 28. Global Parkinson's Disease (PD) Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Parkinson's Disease (PD) Drugs Revenue Share by Company (2018-2023)
    Table 30. Global Market Parkinson's Disease (PD) Drugs Price by Company (2018-2023) & (USD/Pcs)
    Table 31. Global Parkinson's Disease (PD) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
    Table 34. Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
    Table 35. Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Parkinson's Disease (PD) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (K Pcs)
    Table 39. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 43. Global Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (K Pcs)
    Table 44. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
    Table 48. Global Parkinson's Disease (PD) Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (K Pcs)
    Table 50. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Parkinson's Disease (PD) Drugs Price by Application (2018-2023) & (USD/Pcs)
    Table 54. Global Parkinson's Disease (PD) Drugs Sales by Application (2024-2029) & (K Pcs)
    Table 55. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Parkinson's Disease (PD) Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Parkinson's Disease (PD) Drugs Price by Application (2024-2029) & (USD/Pcs)
    Table 59. North America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
    Table 60. North America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
    Table 62. Europe Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
    Table 64. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
    Table 66. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
    Table 68. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 70. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 74. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 78. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 82. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (K Pcs)
    Table 86. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (K Pcs)
    Table 90. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 94. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 98. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 102. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 106. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
    Table 109. Boehringer Ingelheim Company Information
    Table 110. Boehringer Ingelheim Introduction and Business Overview
    Table 111. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 112. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
    Table 113. Boehringer Ingelheim Recent Development
    Table 114. GlaxoSmithKline Company Information
    Table 115. GlaxoSmithKline Introduction and Business Overview
    Table 116. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 117. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product
    Table 118. GlaxoSmithKline Recent Development
    Table 119. Novartis Company Information
    Table 120. Novartis Introduction and Business Overview
    Table 121. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 122. Novartis Parkinson's Disease (PD) Drugs Product
    Table 123. Novartis Recent Development
    Table 124. Teva Pharmaceutical Industries Company Information
    Table 125. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 126. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 127. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product
    Table 128. Teva Pharmaceutical Industries Recent Development
    Table 129. AbbVie Company Information
    Table 130. AbbVie Introduction and Business Overview
    Table 131. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 132. AbbVie Parkinson's Disease (PD) Drugs Product
    Table 133. AbbVie Recent Development
    Table 134. Abital Pharma Company Information
    Table 135. Abital Pharma Introduction and Business Overview
    Table 136. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 137. Abital Pharma Parkinson's Disease (PD) Drugs Product
    Table 138. Abital Pharma Recent Development
    Table 139. Addex Therapeutics Company Information
    Table 140. Addex Therapeutics Introduction and Business Overview
    Table 141. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 142. Addex Therapeutics Parkinson's Disease (PD) Drugs Product
    Table 143. Addex Therapeutics Recent Development
    Table 144. Biogen Company Information
    Table 145. Biogen Introduction and Business Overview
    Table 146. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 147. Biogen Parkinson's Disease (PD) Drugs Product
    Table 148. Biogen Recent Development
    Table 149. Eisai Company Information
    Table 150. Eisai Introduction and Business Overview
    Table 151. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 152. Eisai Parkinson's Disease (PD) Drugs Product
    Table 153. Eisai Recent Development
    Table 154. Eli Lilly Company Information
    Table 155. Eli Lilly Introduction and Business Overview
    Table 156. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 157. Eli Lilly Parkinson's Disease (PD) Drugs Product
    Table 158. Eli Lilly Recent Development
    Table 159. F. Hoffmann-La Roche Company Information
    Table 160. F. Hoffmann-La Roche Introduction and Business Overview
    Table 161. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 162. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product
    Table 163. F. Hoffmann-La Roche Recent Development
    Table 164. H. Lundbeck Company Information
    Table 165. H. Lundbeck Introduction and Business Overview
    Table 166. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 167. H. Lundbeck Parkinson's Disease (PD) Drugs Product
    Table 168. H. Lundbeck Recent Development
    Table 169. Impax Laboratories Company Information
    Table 170. Impax Laboratories Introduction and Business Overview
    Table 171. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 172. Impax Laboratories Parkinson's Disease (PD) Drugs Product
    Table 173. Impax Laboratories Recent Development
    Table 174. Kyowa Hakko Kirin Company Information
    Table 175. Kyowa Hakko Kirin Introduction and Business Overview
    Table 176. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 177. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product
    Table 178. Kyowa Hakko Kirin Recent Development
    Table 179. Otsuka Pharmaceutical Company Information
    Table 180. Otsuka Pharmaceutical Introduction and Business Overview
    Table 181. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 182. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product
    Table 183. Otsuka Pharmaceutical Recent Development
    Table 184. Pfizer Company Information
    Table 185. Pfizer Introduction and Business Overview
    Table 186. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 187. Pfizer Parkinson's Disease (PD) Drugs Product
    Table 188. Pfizer Recent Development
    Table 189. Key Raw Materials Lists
    Table 190. Raw Materials Key Suppliers Lists
    Table 191. Parkinson's Disease (PD) Drugs Market Trends
    Table 192. Parkinson's Disease (PD) Drugs Market Drivers
    Table 193. Parkinson's Disease (PD) Drugs Market Challenges
    Table 194. Parkinson's Disease (PD) Drugs Market Restraints
    Table 195. Parkinson's Disease (PD) Drugs Distributors List
    Table 196. Parkinson's Disease (PD) Drugs Downstream Customers
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinson's Disease (PD) Drugs Product Picture
    Figure 2. Global Parkinson's Disease (PD) Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Parkinson's Disease (PD) Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Parkinson's Disease (PD) Drugs Sales Status and Outlook (2018-2029) & (K Pcs)
    Figure 5. Product Picture of Dopamine Agonist
    Figure 6. Global Dopamine Agonist Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 7. Product Picture of Monoamine Oxidase Inhibitors
    Figure 8. Global Monoamine Oxidase Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 9. Product Picture of Acetylcholinesterase Inhibitors
    Figure 10. Global Acetylcholinesterase Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 11. Product Picture of Glutamate Inhibitors
    Figure 12. Global Glutamate Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 13. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson's Disease (PD) Drugs Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2022
    Figure 27. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Hospital
    Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 30. Product Picture of Family
    Figure 31. Global Family Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 32. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
    Figure 35. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
    Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Parkinson's Disease (PD) Drugs Manufacturing Cost Structure
    Figure 45. Parkinson's Disease (PD) Drugs Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS